Please assess the completion status of the following clinical trial:

Trial Title: XprESS Maxillary Balloon Dilation Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Be at least 18 years of age.~2. Must have uncomplicated sinusitis of the maxillary sinuses with or without anterior ethmoid disease.~3. Meet EITHER the Anthem Coverage Guideline OR BlueCross BlueShield of North Carolina Corporate Medical Policy for medically necessary functional endoscopic sinus surgery (FESS) to treat uncomplicated sinusitis.~4. Have a CT scan within 6 months prior to enrollment.~5. Be mentally and physically capable (as per physician discretion) to participate in the investigation.~6. Be willing and able to sign the study-specific informed consent prior to any study-related procedures.~7. Be willing and able to undergo balloon dilation in the clinic setting.~Exclusion Criteria:~1. Have evidence of posterior ethmoid, sphenoid or frontal sinus (excludes presence of mucous retention cysts) disease requiring endoscopic sinus surgery or balloon dilatation.~2. Have presence of features consistent with sinus fungal disease.~3. Have evidence of gross polypoid disease within any of the sinuses or within the infundibulum.~4. Require concurrent nasal surgery (eg, septoplasty, turbinate reduction, etc).~5. Have previous sinus surgery (eg, sinus surgery or balloon sinuplasty).~6. Have nasal surgery (eg, septoplasty, turbinate reduction) performed within 3 months prior to enrollment.~7. Have any anatomical anomaly (ie, severe septal deviation) preventing transnasal access to the maxillary sinus outflow tract.~8. Have a history of primary ciliary dysfunction.~9. Have hemophilia.~10. Be currently undergoing, or have undergone in the past 6 months, chemotherapy for cancer or radiation therapy in the head or neck region.~11. Have a history of cystic fibrosis.~12. Have Sampter's Triad (ie, defined as having all 3 of the following: aspirin sensitivity, asthma, and sinonasal polyposis).~13. Have known sinonasal tumors or obstructive lesions.~14. Be pregnant at the time of enrollment.~15. Be unable to stop anticoagulant medication (eg, warfarin) until the International Normalized Ratio (INR) is below 1.5.~16. Be unable to stop antiplatelet (eg, clopidogrel, aspirin, etc.) for at least 7 days prior to study procedure.~17. Be currently participating in any other drug or device clinical studies excluding postapproval or marketing registry studies.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Balloon sinus dilation (Type: EXPERIMENTAL): Balloon dilation of the maxillary sinus using a transnasal approach.

Based on this trial design, predict the completion outcome and termination type (if applicable).